Composition
- Active ingredients
- ALISKIREN HEMIFUMARATE EQ 37.5MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ALISKIREN HEMIFUMARATE EQ 300MG BASE · TabletNDA021985-002 · Prescription
- ALISKIREN HEMIFUMARATE EQ 150MG BASE · TabletNDA021985-001 · Prescription
- ALISKIREN HEMIFUMARATE EQ 37.5MG BASE · Capsule, pelletThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA210709.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Tekturna
- Active substance
- aliskiren hemifumarate
- Route
- Oral
- Dosage form
- Capsule, pellet
- Applicant
- Noden Pharma
- Status
- Discontinued
- FDA approval
- 14 Nov 2017
- Application
- NDA210709-001